• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

螺内酯和盐皮质激素受体阻滞剂在心力衰竭中的自主神经效应。

Autonomic effects of spironolactone and MR blockers in heart failure.

作者信息

Davies Justine I, Witham Miles D, Struthers Allan D

机构信息

Department of Clinical Pharmacology, Division of Medicine, Dundee, Scotland, DD1 9SY.

出版信息

Heart Fail Rev. 2005 Jan;10(1):63-9. doi: 10.1007/s10741-005-2350-4.

DOI:10.1007/s10741-005-2350-4
PMID:15947893
Abstract

Neurohormonal dysfunction is an important and potentially modifiable part of the disease process of heart failure. In this review we will discuss the ways in which the autonomic system is deranged in congestive cardiac failure and the different ways we have of monitoring these abnormalities i.e.: heart rate variability, plasma norephinephrine activity, MIBG scanning, heart rate turbulence, baroreceptor function and briefly, microneurographic techniques and QT interval analysis. We will then discuss the direct effects of aldosterone and of aldosterone blockade on some of these parameters. We conclude that neurohormonal dysfunction is an important component of chronic heart failure, which is affected by aldosterone and can be modified by the use of aldosterone receptor blockade.

摘要

神经激素功能障碍是心力衰竭疾病进程中的一个重要且可能可改变的部分。在本综述中,我们将讨论自主神经系统在充血性心力衰竭中紊乱的方式,以及我们监测这些异常的不同方法,即:心率变异性、血浆去甲肾上腺素活性、间碘苄胍扫描、心率震荡、压力感受器功能,简要介绍微神经图技术和QT间期分析。然后我们将讨论醛固酮及其阻断对其中一些参数的直接影响。我们得出结论,神经激素功能障碍是慢性心力衰竭的一个重要组成部分,它受醛固酮影响,并且可以通过使用醛固酮受体阻滞剂来改变。

相似文献

1
Autonomic effects of spironolactone and MR blockers in heart failure.螺内酯和盐皮质激素受体阻滞剂在心力衰竭中的自主神经效应。
Heart Fail Rev. 2005 Jan;10(1):63-9. doi: 10.1007/s10741-005-2350-4.
2
The role of aldosterone blockade in patients with heart failure.醛固酮阻断在心力衰竭患者中的作用。
Heart Fail Rev. 2005 Jan;10(1):79-83. doi: 10.1007/s10741-005-2352-2.
3
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.联合使用盐皮质激素受体拮抗剂和血管紧张素受体拮抗剂可改善心肌梗死后心力衰竭心脏的氧化应激和心功能。
J Cardiovasc Pharmacol. 2012 Aug;60(2):140-9. doi: 10.1097/FJC.0b013e318258f8ce.
4
Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.醛固酮受体拮抗剂——心血管作用如何解释其在心力衰竭中的有益效果。
J Vet Pharmacol Ther. 2010 Apr;33(2):109-17. doi: 10.1111/j.1365-2885.2009.01122.x.
5
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure.醛固酮阻断对充血性心力衰竭患者心率变异性和QT离散度影响的昼夜节律变化。
J Am Coll Cardiol. 2001 Jun 1;37(7):1800-7. doi: 10.1016/s0735-1097(01)01243-8.
6
Aldosterone receptor antagonists.醛固酮受体拮抗剂。
Ann Endocrinol (Paris). 2021 Jun;82(3-4):179-181. doi: 10.1016/j.ando.2020.03.009. Epub 2020 May 27.
7
Aldosterone inhibition and cardiovascular protection: more important than it once appeared.醛固酮抑制与心血管保护:比以往更重要。
Cardiovasc Drugs Ther. 2010 Aug;24(4):345-50. doi: 10.1007/s10557-010-6256-6.
8
Aldosterone antagonists in heart failure.醛固酮拮抗剂在心力衰竭中的应用。
J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):150-9. doi: 10.1177/1074248410387606. Epub 2010 Dec 15.
9
Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.在冠状动脉疾病继发的慢性充血性心力衰竭中,将螺内酯添加到血管紧张素转换酶抑制剂中的效果。
Am J Cardiol. 1995 Dec 15;76(17):1259-65. doi: 10.1016/s0002-9149(99)80353-1.
10
Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure.螺内酯对慢性心力衰竭患者心脏交感神经活性和预后的影响。
Int J Cardiol. 2013 Jul 15;167(1):244-9. doi: 10.1016/j.ijcard.2011.12.080. Epub 2012 Jan 14.

引用本文的文献

1
Heart rate variability in the clinical assessment of patients with chronic liver disease.慢性肝病患者临床评估中的心率变异性
World J Hepatol. 2025 Jul 27;17(7):106291. doi: 10.4254/wjh.v17.i7.106291.
2
Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients.探索血液透析患者中利钠肽与QTc间期的关联。
Ren Fail. 2025 Dec;47(1):2460720. doi: 10.1080/0886022X.2025.2460720. Epub 2025 Feb 17.
3
The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid.脉络膜神经系统:醛固酮受体与脉络膜增厚之间的联系。

本文引用的文献

1
Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes.螺内酯会损害2型糖尿病患者的内皮功能和心率变异性。
Diabetologia. 2004 Oct;47(10):1687-94. doi: 10.1007/s00125-004-1510-8. Epub 2004 Sep 9.
2
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.螺内酯对已接受最佳治疗的轻度心力衰竭患者内皮功能、血管紧张素转换酶活性及其他预后标志物的影响。
Heart. 2004 Jul;90(7):765-70. doi: 10.1136/hrt.2003.017368.
3
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).
Acta Neuropathol. 2023 Nov;146(5):747-766. doi: 10.1007/s00401-023-02628-3. Epub 2023 Sep 8.
4
Identification of Mineralocorticoid Receptors, Aldosterone, and Its Processing Enzyme CYP11B2 on Parasympathetic and Sympathetic Neurons in Rat Intracardiac Ganglia.大鼠心内神经节中副交感和交感神经元上盐皮质激素受体、醛固酮及其加工酶CYP11B2的鉴定
Front Neuroanat. 2022 Jan 11;15:802359. doi: 10.3389/fnana.2021.802359. eCollection 2021.
5
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.依基线心率分层评估依普利酮对射血分数降低型心力衰竭患者主要心血管结局的影响。
Clin Res Cardiol. 2019 Jul;108(7):806-814. doi: 10.1007/s00392-018-1410-4. Epub 2019 Jan 2.
6
The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.心血管自主控制中的肾素-血管紧张素系统:最新进展及其临床意义。
Clin Auton Res. 2019 Apr;29(2):231-243. doi: 10.1007/s10286-018-0572-5. Epub 2018 Nov 9.
慢性心力衰竭患者试验的运动训练荟萃分析(ExTraMATCH)。
BMJ. 2004 Jan 24;328(7433):189. doi: 10.1136/bmj.37938.645220.EE. Epub 2004 Jan 16.
4
Effects of spironolactone and metoprolol on QT dispersion in heart failure.螺内酯和美托洛尔对心力衰竭患者QT离散度的影响。
Jpn Heart J. 2003 Sep;44(5):681-92. doi: 10.1536/jhj.44.681.
5
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy.特发性扩张型心肌病患者室性早搏后心率震荡的预后意义
J Cardiovasc Electrophysiol. 2003 Aug;14(8):819-24. doi: 10.1046/j.1540-8167.2003.03085.x.
6
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.依普利酮,一种选择性醛固酮阻滞剂,用于心肌梗死后左心室功能不全的患者。
N Engl J Med. 2003 Apr 3;348(14):1309-21. doi: 10.1056/NEJMoa030207. Epub 2003 Mar 31.
7
Long QTc predicts future cardiac death in stroke survivors.长QTc可预测卒中幸存者未来的心脏性死亡。
Heart. 2003 Apr;89(4):377-81. doi: 10.1136/heart.89.4.377.
8
Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.螺内酯对扩张型心肌病患者心脏交感神经活动及左心室重构的影响。
J Am Coll Cardiol. 2003 Feb 19;41(4):574-81. doi: 10.1016/s0735-1097(02)02855-3.
9
Induction of heart rate and blood pressure turbulence in the electrophysiologic laboratory.在电生理实验室中诱发心率和血压波动。
Am J Cardiol. 2002 Nov 15;90(10):1098-102. doi: 10.1016/s0002-9149(02)02775-3.
10
Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure.用氨氯吡咪增加血浆钾可缩短QT间期并减少室性期前收缩,但在慢性心力衰竭中不会改变内皮功能或心率变异性。
Heart. 2002 Nov;88(5):475-80. doi: 10.1136/heart.88.5.475.